BUZZ-MiNK Therapeutics rises as it wins funding for child cancer cell therapy
Reuters03-10
BUZZ-MiNK <a href="https://laohu8.com/S/LENZ">Therapeutics</a> rises as it wins funding for child cancer cell therapy
** Shares of drug developer MiNK Therapeutics INKT.O rise 53.40% to $5.58 premarket
** Co says it will receive up to $1.1 mln from C-Further to develop a cell therapy for childhood cancers
** Therapy targets PRAME, a protein linked to hard‑to‑treat cancers including sarcomas, acute myeloid leukemia and medulloblastoma, co says
** Co says donor‑derived immune cells are designed to allow faster treatment without complex matching
** Researchers at University of Southampton to run preclinical safety and efficacy studies, co says
** Co's lead candidate, agenT‑797, is already being tested for other conditions - INKT
** Share up ~60% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments